Category: Activities

Date: Tuesday 3 November 2026 (4 pm EAT) About the speaker Dr. William Denney is the Founder and Chief Scientific Officer of Human Predictions with over 20 years of experience in mathematical modeling and clinical pharmacology. Before founding Human Predictions, he worked at Pfizer and Merck, advancing clinical pharmacology, pharmacokinetics, and pharmacodynamics by designing development strategies, optimizing trials, and building models to improve efficiency. His career combines deep experience in pharmacometrics, clinical trial design, model-based meta-analysis, and applied computer science, enabling innovative approaches to streamline drug development. Bill is recognized for developing open-source tools and methods that enhance transparency, precision, and impact in pharmaceutical research and development. About this series Sharing knowledge, presenting advances and discussing best practices in pharmacometrics, featuring locally-relevant case studies in application of PBPK and pop-PK Who should attend: Anyone interested in learning how pharmacometrics helps to enable safe and effective use of medication Cost: Totally Free

Date: Tuesday 6 October 2026 (4 pm EAT) About the speaker Stacey Tannenbaum, PhD, FISoP offers training and coaching in leadership, communication, and professional skills to MIDD scientists.  She spent 25+ years in Pharma and consulting as a PKPD scientist and leader, including roles at MetrumRG, Astellas, and Novartis.   She is a sought after public speaker, with demonstrated expertise in coaching on impactful scientific presentation development and execution, and has supported scientists in attainment of critical strengths such as negotiation, conflict resolution, change management, and relationship building with teams and collaborators.   Stacey has served the Pharmacometrics community as a volunteer leader for many years.  She co-founded both ISoP and ACoP and remains an active volunteer in both, and is an ISoP fellow and the first President of the organization.  She is Past Chair of the Quantitative Pharmacology Network of ASCPT, and has served the Executive Committee for WCoP since 2016, and co-chaired the 2022 conference in Cape Town.  Stacey served AAPS as an Executive Council member and M&S Focus Group chair, and participated in several AAPS committees and initiatives. About this series Sharing knowledge, presenting advances and discussing best practices in pharmacometrics, featuring locally-relevant case studies in application of PBPK and pop-PK Who should attend: Anyone interested in learning how pharmacometrics helps to enable safe and effective use of medication Cost: Totally Free

Download the slides here Date: Tuesday 11 August 2026 (4 pm Ugandan Time) About the speaker Aida Kawuma, PhD is a founding member of the Ugandan Chapter of Pharmacometrics Africa. She is passionate about improving the contributions of African scientists in pharmacology and pharmacometrics. She is a scientist at Pumas-AI with expertise in population PK/PD modelling and model-informed drug development across a diverse range of molecules and disease areas. She is also a member of the MILK Centre modelling group at the Infectious Diseases Institute, Makerere University. About this series Sharing knowledge, presenting advances and discussing best practices in pharmacometrics, featuring locally-relevant case studies in application of PBPK and pop-PK Who should attend: Anyone interested in learning how pharmacometrics helps to enable safe and effective use of medication Cost: Totally Free

Date: Tuesday 24 March 2026 (2 pm Ugandan Time) About the speaker Francis Williams Ojara is a Post-doctoral pharmacometric modeler at the Infectious Diseases Institute and a lecturer of pharmacology at Gulu University. He holds a Doctorate in Natural Sciences (focusing on Pharmacometrics). His research covers modelling of pharmacokinetic-(and pharmacodynamic) data in oncology and infectious diseases, with current interests in understudied populations such as the pediatrics and pregnant mothers. He has strong interest in training and mentoring scholars into pharmacometrics and establishing potent global networks to support the growth of pharmacometrics in Uganda and Africa. About this series Sharing knowledge, presenting advances and discussing best practices in pharmacometrics, featuring locally-relevant case studies in application of PBPK and pop-PK Who should attend: Anyone interested in learning how pharmacometrics helps to enable safe and effective use of medication Cost: Totally Free

11 November 20252:00 PM – 3:00 PM EAT (1h) About the speaker Bernd Meibohm, PhD, FCP, FAAPS is a UTHSC Distinguished Professor of Pharmaceutical Sciences and Associate Dean for Research and Graduate Programs at the College of Pharmacy, The University of Tennessee Health Science Center, Memphis, Tennessee, USA.  He also serves as Chair of the University of Tennessee Department of Pharmaceutical Sciences and holds the Harriet S. Van Fleet Endowed Professorship in Pharmaceutics. Dr. Meibohm received his pharmacy degree and doctorate in pharmaceutics from Technical University Carolo-Wilhelmina, Braunschweig, Germany. After completion of a clinical pharmacology research fellowship at the University of Florida in 1997, he joined the faculty of the University of South Carolina, and in 1999 the University of Tennessee.  Dr. Meibohm’s scientific interests include bacterial and viral infectious diseases, pediatric pharmacotherapy and the application of pharmacometric modeling and simulation techniques in preclinical and clinical drug development, with specific focus on therapeutic proteins.  His research has resulted in over 230 scientific papers and book chapters (>14,000 citations; h-index 58), three textbooks, 200 abstracts, and over 250 invited scientific presentations to national and international audiences. Dr. Meibohm is a Fellow of the American Association of Pharmaceutical Scientists (AAPS) and the American College of Clinical Pharmacology (ACCP). He was the President of ACCP 2014-2016 and served on its Board of Regents 2008-2018. He also served as 2010 Chair for the ‘Pharmacokinetics, Pharmacodynamics and Drug Metabolism’ section of AAPS, as 2016-2019 Member-at-Large on the Board of Directors of AAPS, and has recently